Drug Type Small molecule drug, Liposomal Drug |
Synonyms LiPax, PLIP, LEIPC-1007 + [8] |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC47H51NO14 |
InChIKeyRCINICONZNJXQF-MZXODVADSA-N |
CAS Registry33069-62-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Muscle Invasive Bladder Neoplasms | Phase 2 | United States | 17 May 2018 | |
Urothelial Carcinoma of the Urinary Bladder | Phase 2 | United States | 17 May 2018 | |
Malignant Pleural Effusion | Preclinical | United States | 11 Jun 2024 | |
Ovarian Cancer | Preclinical | United States | 11 Jun 2024 | |
Peritoneal Neoplasms | Preclinical | United States | 11 Jun 2024 |
Not Applicable | 444 | qemxnuxwqn(noxsnmwkkm) = csygeuwaku qfnyfnxraq (gpzqszrunq ) View more | - | 31 May 2023 | |||
qemxnuxwqn(noxsnmwkkm) = owohugztud qfnyfnxraq (gpzqszrunq ) View more | |||||||
Not Applicable | Advanced Gastric Adenocarcinoma Third line | 73 | hijgnaxxee(padpdsoewp) = qlqvoqhugn msvbjhburf (jvwofgtxmw ) View more | - | 24 Jan 2023 | ||
Not Applicable | Non-Small Cell Lung Cancer Third line | 52 | Taxanes-based chemotherapy alone | tgmirmeppe(uemirmyzxc) = qzocqixvwk ouxqucwwxt (kabjhwquhg ) | Positive | 10 Sep 2022 | |
Taxanes-based chemotherapy plus angiogenesis inhibitors | tgmirmeppe(mqqzocbxtr) = shvewuwrxy induglkvew (pdlalqdhwl ) | ||||||
Not Applicable | 99 | kuotzwtvqk(wpxoibwuva) = woruhzuwpc fncxckujwq (oqzujlvoxp ) View more | - | 02 Jun 2022 | |||
vqeggbxsxr(gatiwcnpsj) = knbocfabhq owgyaniexv (kfmixcagme ) | |||||||
Not Applicable | 40 | zmdcqprszk(nlipdonflt) = tiksbkxerd ppshdwqkjb (jtebzfmnhw ) | - | 25 May 2020 | |||
NCT03081858 (Biospace) Manual | Phase 1/2 | 6 | hbjwbsqnui(rmxfqvsztc) = rlyqfbnjxs fzohztseso (qaidbnmnhv ) View more | Positive | 18 May 2020 | ||
Not Applicable | - | (High glutamine levels) | utnkncwxln(cmpdlvrwzw) = pyiddvpmqt oidmkzzeph (pgffnjkyei ) View more | Positive | 19 Feb 2020 | ||
(Low glutamine levels) | utnkncwxln(cmpdlvrwzw) = rpjukwfunh oidmkzzeph (pgffnjkyei ) View more | ||||||
Not Applicable | - | cqjyuqgoef(kdtkoyzejr) = iwyzkikddu lzkzfwyuyc (awiezrzwpc ) View more | Positive | 26 Feb 2019 | |||
cqjyuqgoef(kdtkoyzejr) = ccysqkurzv lzkzfwyuyc (awiezrzwpc ) View more | |||||||
Not Applicable | Breast Cancer Adjuvant | - | pvjdobpgry(osaiveczqj) = eqlaatupfy pfjhmvprfc (kzzkocxojr ) | - | 22 Oct 2018 | ||
Cyclophosphamide + Anthracycline combination (TaxAC) | pvjdobpgry(osaiveczqj) = tpbxcltokq pfjhmvprfc (kzzkocxojr ) | ||||||
Not Applicable | 63 | Chemotherapy based on anthracyclines and taxanes | wyvtbofjba(jnlrntasls) = solvthpbxt rioptencyq (wtblhutvxe ) | - | 01 Jul 2017 |